JP2004501132A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004501132A5 JP2004501132A5 JP2002504212A JP2002504212A JP2004501132A5 JP 2004501132 A5 JP2004501132 A5 JP 2004501132A5 JP 2002504212 A JP2002504212 A JP 2002504212A JP 2002504212 A JP2002504212 A JP 2002504212A JP 2004501132 A5 JP2004501132 A5 JP 2004501132A5
- Authority
- JP
- Japan
- Prior art keywords
- dichloro
- alkyl
- acid
- alkenyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0015205.8A GB0015205D0 (en) | 2000-06-21 | 2000-06-21 | Bioisosteric thyroid receptor ligands and method |
| PCT/EP2001/006815 WO2001098256A1 (en) | 2000-06-21 | 2001-06-15 | Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004501132A JP2004501132A (ja) | 2004-01-15 |
| JP2004501132A5 true JP2004501132A5 (enExample) | 2008-07-10 |
Family
ID=9894112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002504212A Withdrawn JP2004501132A (ja) | 2000-06-21 | 2001-06-15 | 甲状腺受容体リガンド、それらを含む薬学的組成物、および甲状腺ホルモンにより影響を及ぼされる障害の治療におけるそれらの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7199265B2 (enExample) |
| EP (1) | EP1296936A1 (enExample) |
| JP (1) | JP2004501132A (enExample) |
| KR (1) | KR20030058952A (enExample) |
| AU (1) | AU779880B2 (enExample) |
| CA (1) | CA2412161C (enExample) |
| GB (1) | GB0015205D0 (enExample) |
| WO (1) | WO2001098256A1 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7163918B2 (en) * | 2000-08-22 | 2007-01-16 | New River Pharmaceuticals Inc. | Iodothyronine compositions |
| US20040242594A1 (en) * | 2001-11-17 | 2004-12-02 | Dan Peters | Prodrugs of antidepressants and their use for treating depressions |
| GB0208384D0 (en) * | 2002-04-11 | 2002-05-22 | Karobio Ab | Novel compounds |
| US7518033B2 (en) * | 2002-08-02 | 2009-04-14 | The General Hospital Corporation | Methods for the production of cells and mammals with desired genetic modifications |
| FR2858232B1 (fr) * | 2003-07-29 | 2006-03-03 | Pierre Potier | Utilisation d'un derive de biguanide pour proteger la peau des radiations uvb |
| EP2428516A1 (en) | 2003-11-19 | 2012-03-14 | Metabasis Therapeutics, Inc. | Novel phosphorus-containing thyromimetics |
| WO2005054176A1 (en) * | 2003-11-25 | 2005-06-16 | Eli Lilly And Company | Peroxisome proliferator activated receptor modulators |
| WO2005090297A1 (en) * | 2004-03-19 | 2005-09-29 | Biotie Therapies Corporation | Sulphonamide derivatives |
| GB0406380D0 (en) * | 2004-03-22 | 2004-04-21 | Karobio Ab | Novel pharmaceutical compositions |
| GB0406378D0 (en) * | 2004-03-22 | 2004-04-21 | Karobio Ab | Novel pharmaceutical compositions |
| US8188277B2 (en) | 2004-08-06 | 2012-05-29 | Otsuka Pharmaceutical Co., Ltd. | Aromatic compounds for suppressing the generation of collagen |
| US20060039890A1 (en) * | 2004-08-20 | 2006-02-23 | Renshaw Perry F | Treatment of psychological and cognitive disorders using a cholesterol -lowering agent in combination with an antidepressant |
| CA2578999A1 (en) * | 2004-09-01 | 2006-03-16 | Trustees Of Boston University | Use of thyroid hormone conversion inhibitors |
| RU2007148927A (ru) * | 2005-05-26 | 2009-07-10 | Метабэйзис Терапьютикс, Инк. (Us) | Новые тиреомиметики, содержащие фосфиновую кислоту |
| US20090232879A1 (en) | 2005-05-26 | 2009-09-17 | Metabasis Therapeutics, Inc. | Thyromimetics for the Treatment of Fatty Liver Diseases |
| GB0513692D0 (en) * | 2005-07-04 | 2005-08-10 | Karobio Ab | Novel pharmaceutical compositions |
| EP1957073B1 (en) | 2005-12-05 | 2014-04-23 | Otsuka Pharmaceutical Co., Ltd. | Medicinal drug |
| GB0608724D0 (en) | 2006-05-03 | 2006-06-14 | Karobio Ab | Novel Pharmaceutical Compositions |
| ES2396715T3 (es) | 2006-08-21 | 2013-02-25 | Array Biopharma, Inc. | Derivados de ácido fenoxifenilacético 4-sustituido |
| UA95978C2 (ru) | 2006-10-02 | 2011-09-26 | Оцука Фармас'Ютікел Ко., Лтд. | Ингибитор активации stat3/5 |
| GB0725214D0 (en) * | 2007-12-24 | 2008-02-06 | Karobio Ab | Pharmaceutical compounds |
| JP2011088826A (ja) * | 2008-01-31 | 2011-05-06 | Astellas Pharma Inc | 芳香族カルボン酸化合物 |
| KR101396606B1 (ko) | 2009-04-20 | 2014-05-16 | 미쓰비시 타나베 파마 코퍼레이션 | 신규 갑상선 호르몬 β 수용체 작동약 |
| US9605112B2 (en) | 2009-10-11 | 2017-03-28 | Rutgers, The State University Of New Jersey | Biocompatible polymers for medical devices |
| EP2809702B1 (en) | 2012-02-03 | 2017-12-20 | Rutgers, The State University of New Jersey | Polymeric biomaterials derived from phenolic monomers and their medical uses |
| US11472918B2 (en) | 2012-02-03 | 2022-10-18 | Rutgers, The State University Of New Jersey | Polymeric biomaterials derived from phenolic monomers and their medical uses |
| US10774030B2 (en) | 2014-12-23 | 2020-09-15 | Rutgers, The State University Of New Jersey | Polymeric biomaterials derived from phenolic monomers and their medical uses |
| AU2015370426B2 (en) | 2014-12-23 | 2019-09-12 | Rutgers, The State University Of New Jersey | Biocompatible iodinated diphenol monomers and polymers |
| WO2018094265A2 (en) | 2016-11-21 | 2018-05-24 | Viking Therapeutics, Inc. | Method of treating glycogen storage disease |
| AU2018280118B2 (en) | 2017-06-05 | 2021-07-15 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis |
| EP3683306A4 (en) | 2017-09-14 | 2021-06-09 | Riken | METHOD FOR MANUFACTURING RETINAGE TISSUE |
| EA202091979A1 (ru) | 2018-03-22 | 2021-06-22 | Вайкинг Терапьютикс, Инк. | Кристаллические формы и способы получения кристаллических форм соединения |
| EP4775207A2 (en) | 2018-12-05 | 2026-07-15 | Viking Therapeutics, Inc. | Compositions for the treatment of fibrosis |
| CN121081472A (zh) | 2018-12-13 | 2025-12-09 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| SG11202109855PA (en) | 2019-03-13 | 2021-10-28 | Sumitomo Dainippon Pharma Co Ltd | Method for evaluating quality of transplant neural retina, and transplant neural retina sheet |
| WO2020227549A1 (en) | 2019-05-08 | 2020-11-12 | Aligos Therapeutics, Inc. | MODULATORS OF THR-β AND METHODS OF USE THEREOF |
| CA3154488A1 (en) * | 2019-08-23 | 2021-03-04 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| CA3154391A1 (en) | 2019-09-12 | 2021-03-18 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| EP4161925A4 (en) | 2020-06-09 | 2024-09-04 | Viking Therapeutics, Inc. | COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIVER DISEASES |
| EP4201428A4 (en) | 2020-09-11 | 2024-09-11 | Sumitomo Pharma Co., Ltd. | MEDIUM FOR TISSUE INTENDED FOR TRANSPLANTATION |
| JPWO2022054925A1 (enExample) | 2020-09-11 | 2022-03-17 | ||
| US11793815B2 (en) | 2020-11-06 | 2023-10-24 | Aligos Therapeutics, Inc. | Oxindoles and methods of use thereof |
| KR20240103018A (ko) | 2021-11-19 | 2024-07-03 | 고쿠리쓰 겐큐 가이하쓰 호징 리가가쿠 겐큐소 | 시트상 망막 조직의 제조 방법 |
| PE20252787A1 (es) | 2023-04-07 | 2025-12-22 | Terns Pharmaceuticals Inc | Combinacion que comprende un agonista de thr-beta y un agonista de glp-1r para su uso en el tratamiento de un trastorno hepatico o una enfermedad cardiometabolica |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB642159A (en) * | 1947-10-23 | 1950-08-30 | Glaxo Lab Ltd | Improvements in or relating to the preparation of diphenyl ethers |
| GB643089A (en) * | 1947-10-23 | 1950-09-15 | Glaxo Lab Ltd | Improvements in or relating to the preparation of 2:6-dihalogeno diphenyl ethers |
| US3652665A (en) * | 1970-04-20 | 1972-03-28 | Merck & Co Inc | Halo-phenoxy salicylic acids |
| US4465508A (en) * | 1979-07-18 | 1984-08-14 | Imperial Chemical Industries Plc | Diphenyl ether herbicides |
| EP0580550B1 (en) * | 1992-07-21 | 1997-10-22 | Novartis AG | Oxamic acid derivatives as hypocholesteremic agents |
| GB9416219D0 (en) | 1994-08-11 | 1994-10-05 | Karobio Ab | Receptor ligands |
| DE19527305A1 (de) * | 1995-07-26 | 1997-01-30 | Hoechst Ag | Substituierte Zimtsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US5883294A (en) * | 1997-06-18 | 1999-03-16 | The Regeants Of The University Of California | Selective thyroid hormone analogs |
| WO2000051971A1 (en) * | 1999-03-01 | 2000-09-08 | Pfizer Products Inc. | Oxamic acids and derivatives as thyroid receptor ligands |
-
2000
- 2000-06-21 GB GBGB0015205.8A patent/GB0015205D0/en not_active Ceased
-
2001
- 2001-06-15 KR KR1020027017478A patent/KR20030058952A/ko not_active Withdrawn
- 2001-06-15 AU AU72484/01A patent/AU779880B2/en not_active Ceased
- 2001-06-15 EP EP01951600A patent/EP1296936A1/en not_active Withdrawn
- 2001-06-15 WO PCT/EP2001/006815 patent/WO2001098256A1/en not_active Ceased
- 2001-06-15 CA CA002412161A patent/CA2412161C/en not_active Expired - Fee Related
- 2001-06-15 JP JP2002504212A patent/JP2004501132A/ja not_active Withdrawn
- 2001-06-15 US US10/311,524 patent/US7199265B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1379507B1 (en) | HETEROARYL UREAS CONTAINING NITROGEN HETERO-ATOMS AS p38 KINASE INHIBITORS | |
| JP2866744B2 (ja) | 眼の炎症障害を処置するための３‐ベンゾイルフェニル酢酸誘導体を含む局所的に投与可能な組成物 | |
| JP3778516B2 (ja) | 新規なアリールプロピオン酸誘導体、その製造方法及び鎮痛薬としてのその用途 | |
| RU2001120701A (ru) | Новые лиганды тиреоидных рецепторов | |
| JP5927236B2 (ja) | 乾癬を予防または低減する方法 | |
| RU2006141416A (ru) | Пролекарства леводопа, композиции на их основе и их применения | |
| CA2526534A1 (en) | Compounds and methods for delivery of prostacyclin analogs | |
| EP2647619B1 (en) | Novel compound and medical use thereof | |
| JP2007502806A5 (enExample) | ||
| JPH09512798A (ja) | 消炎、鎮痛および抗血栓活性を有するニトロ化合物およびそれらの組成物 | |
| RU2001113733A (ru) | N-(2-арилпропионил) сульфонамиды и содержащие их фармацевтические препараты | |
| JPH0657685B2 (ja) | ５α―リダクターゼ阻害活性を有するベンゾイルアミノフェノキシブタン酸誘導体、それらの製造方法およびそれらを含有する薬剤 | |
| JP2828293B2 (ja) | 神経系退行性変質のためのｌ―カルニチン誘導体治療剤 | |
| JP2012131829A (ja) | そう痒状態の処置のためのｍｇｌｕｒ５アンタゴニストの使用 | |
| JPH07107037B2 (ja) | ５α−リダクターゼ阻害活性を有するベンゾイルアミノフェノキシブタン酸誘導体およびそれらを有効成分として含有する薬剤 | |
| RU2002101622A (ru) | Нафтохиноновые производные и их использование для лечения и борьбы с туберкулезом | |
| RU2005137571A (ru) | Новые производные диазабициклононена | |
| UA42686C2 (uk) | Похідні 3-хінуклідилових ефірів, проміжні сполуки та спосіб одержання 3-хінуклідилових ефірів, фармацевтична композиція, що має антимускаринову дію, та спосіб лікування хронічних обструктивних захворювань дихальних шляхів або астми | |
| JP2003500466A5 (enExample) | ||
| EP2265267B1 (en) | Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections | |
| MXPA02001740A (es) | Uso de bis-sulfonamidas para producir medicinas para la profilaxis o tratamiento de hiperlipidemia. | |
| HUP0303399A2 (hu) | Foszfodiészteráz IV gátló hatású gyógyászati készítmények előállítására alkalmas vegyületek | |
| RU2005136431A (ru) | 4-, 6-или 7-гидроксииндолы с n-оксидными группами и их применение в качестве терапевтических средств | |
| KR980002020A (ko) | 오르토-치환된 벤조일구아니딘, 이의 제조방법, 약물 또는 진단제로서의 이의 용도 및 이를 포함하는 약제 | |
| JP2003521500A5 (enExample) |